Healthy adults
Conditions
Interventions
Take sixteen tablets a day, once or twice daily.
Sponsors
IMEQRD Co., Ltd
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Aged over 20 years of age and less than 50 years of age. 2. Male adults. 3. BMI over 18.5 kg/m^2 and less than 30.0kg/m^2. 4. Have contracted an upper respiratory infection more than once a year. 5. Who can use smartphones or PC to record a daily diary. 6. Received a sufficient explanation for the study objective, and voluntarily joined the study with the agreement to informed consent.
Exclusion criteria
Exclusion criteria: 1. Currently receiving any medical treatment with drugs or Chinese herbs. Medications used as needed are acceptable. 2. Receive diet or exercise therapy under medical supervision. 3. Have serious illnesses or a history of serious illnesses. 4. Have immune disorders such as atopic dermatitis, allergic rhinitis, bronchial asthma, and chronic bronchitis. 5. Voluntarily consume yogurt or beverages containing lactic acid bacteria and bifidobacteria more than three times a week. 6. Have been taking foods or dietary supplements with functional health claims that affect the outcome of the study more than three times per week. 7. Be vaccinated against influenza viruses or SARS-CoV-2 within one month before the first study visit, or have the plan to be vaccinated during the study. 8. Have allergies to drugs or foods. 9. Workers on night shifts or with irregular work schedules. 10. Who plans for significant changes in lifestyle, such as eating habits, sleep duration, or exercise habits. 11. Alcohol drinking over an average of 40g/day per week. 12. Who plans to travel abroad during the study period. 13. Have above 200 mL blood donation within one month before the start period of the study, or have above 400 mL blood donation within three months before the start period of the study. 14. Those who have participated in other clinical trials within one month before enrolling in the study, those who are currently participating in other clinical trials, and those who plan to participate in other clinical trials after enrolling in the study. 15. Who are unsuitable for the study, as determined by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| immunological parameters | — |
Countries
Japan
Contacts
Public ContactYoshitada Hira
IMEQRD Co., Ltd. Planning and Sales Department
Outcome results
None listed